IOSP Innospec Inc.
$99.18▲ +0.55%
Materials
Other
Pre-market
$99.18▲ +0.00%
Oct 27, 4:22 AM ET
Volume 126.9K
Avg Volume (10D) 250.5K
Key Metrics & Fundamentals
Market Cap
$2.44B
P/E Ratio
20.2
Div Yield
1.80%
52W Range
65.51 - 100.62
% vs 50 MA
3.88%
% vs 200 MA
18.11%
RSI-14
61.1
MACD Histogram
+0.0600
Beta (1Y vs SPY)
0.51
Free Cash Flow
-$10.50M
Gross Rev
$491.40M
Gross Profit
$138.30M
EBITDA
$49.90M
COGS
$353.10M
Operating Exp
$98.50M
Operating Income
$39.80M
EBIT
$39.80M
Pretax Income
$41.60M
Net Income
$30.80M
EPS (Diluted)
1.25
Price & Volume History
Loading chart…
Recent News

Are Basic Materials Stocks Lagging Avient (AVNT) This Year?
Zacks · Oct 16, 2026 8:40 AM ET

Innospec Schedules Third Quarter 2026 Earnings Release and Conference Call
GlobeNewswire · Oct 5, 2026 4:45 PM ET

Here's Why You Should Hold DOW Stock in Your Portfolio for Now
Zacks · Oct 5, 2026 7:27 AM ET

Freeport-McMoRan Reports Q3 Copper Output, Advances Grasberg Recovery
Zacks · Oct 5, 2026 7:11 AM ET

Avient Advances Circularity by Launching Nymax FR REC Flame Retardant
Zacks · Oct 2, 2026 8:05 AM ET

RYAM Strengthens Jesup Operations With Altamaha Green Energy Project
Zacks · Oct 1, 2026 10:17 AM ET

Hawkins Expands Texas Water Treatment With Eagle Labs Buyout
Zacks · Oct 1, 2026 7:01 AM ET

Tronox and JX Advanced Strengthen Rare Earth Development Projects
Zacks · Sep 30, 2026 7:02 AM ET

ASH's Shares Rally 30% in 6 Months: What's Driving the Upside?
Zacks · Sep 29, 2026 7:07 AM ET

Nucor's Shares Rally 50% in 6 Months: What's Driving the Momentum?
Zacks · Sep 28, 2026 7:55 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See IOSP's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.